🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate if postoperative antibiotic use in ...
Status
Terminated
Location
Memorial Hermann Hospital
Start Date
2020-10-01
Trial ID
NCT04198129
The aim of this study is to evaluate the efficacy of daily intake of fortif...
Status
Unknown
Location
Laboratory of Nutrition Research, National Nutrition and Food Technology Research Institute (NNFTRI) and Faculty of Nutrition Science and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Start Date
2021-12-01
Trial ID
NCT05271045
Treatments Being Tested
The goal of this clinical trial is to determine whether topical tripelennam...
Status
Completed
Location
Palm Beach Atlantic University
Start Date
2025-02-24
Trial ID
NCT07778472
Treatments Being Tested
The aim of this study is to compare the impact of hypoglycaemia treatment i...
Status
Completed
Location
Marmara University
Start Date
2024-12-01
Trial ID
NCT07711275
Treatments Being Tested
The interventional study will evaluate the effects of a regularly consumpti...
Status
Completed
Location
Friedrich-Schiller-University
Start Date
2018-05-02
Trial ID
NCT03648112
Treatments Being Tested
Sensory innervation of the femoral region which is the entry point for endo...
Status
Recruiting
Location
Istanbul University- Cerrahpasa
Start Date
2024-09-10
Trial ID
NCT06576128
Treatments Being Tested
Lurbinectedin is mainly eliminated by the liver. Thus, Hepatic Impairment (...
Status
Unknown
Location
Hospital Universitario Virgen de la Victoria
Start Date
2021-03-09
Trial ID
NCT05101265
Treatments Being Tested
The purpose of this study is to compare the efficacy of Photodynamic Therap...
Status
Completed
Location
Spencer Dermatology and Skin Surgery
Start Date
2007-09
Trial ID
NCT00306800
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested